Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol
- 31 January 2003
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (1) , 31-37
- https://doi.org/10.1016/s0959-8049(02)00529-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 2000
- Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group studyEuropean Journal of Haematology, 1999
- Multiple MyelomaNew England Journal of Medicine, 1997
- Expression of p170 protein in multiple myeloma: A clinical studyHematological Oncology, 1992
- Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.Journal of Clinical Pathology, 1990
- Early Plasma Cell Recruitment In Multiple Myeloma Following ChemotherapyCell Proliferation, 1988
- Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1986
- Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic featuresEuropean Journal of Cancer and Clinical Oncology, 1984
- Treatment of multiple myeloma with M-2 protocol and without maintenance therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- REAPPRAISAL OF PLATEAU PHASE IN MYELOMAThe Lancet, 1980